Literature DB >> 1509780

Plasma and tissue alterations of peptide YY and enteroglucagon in rats after colectomy.

A P Vukasin1, G H Ballantyne, O Nilsson, A J Bilchik, T E Adrian, I M Modlin.   

Abstract

Peptide YY (PYY) and enteroglucagon are produced by endocrine cells of the colonic mucosa. PYY inhibits upper gastrointestinal motility, and enteroglucagon is trophic for small bowel mucosa. Adaptive increase in the production and release of these peptides may improve functional results after colorectal resections. We hypothesized that if segments of the colon were resected, then production and release of PYY and enteroglucagon would increase in the remaining segments of bowel. Animals which underwent colonic transections and partial resections had transient elevations of PYY up to 250 +/- 80 pmol/L, which dropped to control group levels in the second week following surgery. Rats with an abdominal colectomy had significantly greater PYY levels than all other groups from the third (208 +/- 30 pmol/L) to the thirty-eighth (100 +/- 16 pmol/L) week of the study. Circulating levels of enteroglucagon were elevated to 156 +/- 35 pmol/L in rats with a right hemicolectomy during the first week following surgery. Enteroglucagon levels did not significantly vary in the other groups studied. Both tissue PYY (413 +/- 33 pmol/gram) and tissue enteroglucagon (171 +/- 17 pmol/gram) were significantly elevated in the rectums of the rats with an abdominal colectomy, as compared to all other groups. The elevated tissue levels may thus account for the ability to maintain elevated plasma PYY. Double immunogold labeling of endocrine cells in the colorectal tissue for PYY and enteroglucagon revealed both peptides within the same endocrine cells and secretory granules. These studies support the hypothesis that circulating levels of PYY are elevated after major colonic resections and suggest that L-type endocrine cells may participate in adaptive responses which improve intestinal function following colonic surgery.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1509780      PMCID: PMC2589382     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  40 in total

1.  Demonstration and characterization of a second fraction of glucagon-like immunoreactivity in jejunal extracts.

Authors:  I Valverde; D Rigopoulou; J Exton; A Ohneda; A Eisentraut; R H Unger
Journal:  Am J Med Sci       Date:  1968-06       Impact factor: 2.378

2.  Tissue localization and relative distribution of regulatory peptides in separated layers from the human bowel.

Authors:  G L Ferri; T E Adrian; M A Ghatei; D J O'Shaughnessy; L Probert; Y C Lee; A M Buchan; J M Polak; S R Bloom
Journal:  Gastroenterology       Date:  1983-04       Impact factor: 22.682

3.  Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide.

Authors:  D Bataille; K Tatemoto; C Gespach; H Jörnvall; G Rosselin; V Mutt
Journal:  FEBS Lett       Date:  1982-09-06       Impact factor: 4.124

4.  Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas.

Authors:  A Ali-Rachedi; I M Varndell; T E Adrian; D A Gapp; S Van Noorden; S R Bloom; J M Polak
Journal:  Histochemistry       Date:  1984

5.  Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion.

Authors:  K Tatemoto
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

6.  Gut hormones in inflammatory bowel disease.

Authors:  H S Besterman; C N Mallinson; R Modigliani; N D Christofides; A Pera; V Ponti; D L Sarson; S R Bloom
Journal:  Scand J Gastroenterol       Date:  1983-10       Impact factor: 2.423

7.  The ileal brake--inhibition of jejunal motility after ileal fat perfusion in man.

Authors:  R C Spiller; I F Trotman; B E Higgins; M A Ghatei; G K Grimble; Y C Lee; S R Bloom; J J Misiewicz; D B Silk
Journal:  Gut       Date:  1984-04       Impact factor: 23.059

8.  Plasma enteroglucagon and CCK levels and cell proliferation in defunctioned small bowel in the rat.

Authors:  G E Gornacz; M A Ghatei; M Y Al-Mukhtar; J C Yeats; T E Adrian; N A Wright; S R Bloom
Journal:  Dig Dis Sci       Date:  1984-11       Impact factor: 3.199

9.  Immunocytochemical identification of polypeptide YY (PYY) cells in the human gastrointestinal tract.

Authors:  M El-Salhy; L Grimelius; E Wilander; B Ryberg; L Terenius; J M Lundberg; K Tatemoto
Journal:  Histochemistry       Date:  1983

10.  Isolation of two novel candidate hormones using a chemical method for finding naturally occurring polypeptides.

Authors:  K Tatemoto; V Mutt
Journal:  Nature       Date:  1980-06-05       Impact factor: 49.962

View more
  2 in total

1.  Gastric emptying rate of solids is reduced in a group of ileostomy patients.

Authors:  M D Robertson; J C Mathers
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

2.  Peptide YY selectively stimulates expression of the colonocytic phenotype.

Authors:  S A Sgambati; G A Turowski; M D Basson
Journal:  J Gastrointest Surg       Date:  1997 Nov-Dec       Impact factor: 3.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.